Literature DB >> 22009534

PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.

Maya Zigler1, Takafumi Kamiya, Emily C Brantley, Gabriel J Villares, Menashe Bar-Eli.   

Abstract

Progression of melanoma is dependent on cross-talk between tumor cells and the adjacent microenvironment. The thrombin receptor, protease-activated receptor-1 (PAR-1), plays a key role in exerting this function during melanoma progression. PAR-1 and its activating factors, which are expressed on tumor cells and the surrounding stroma, induce not only coagulation but also cell signaling, which promotes the metastatic phenotype. Several adhesion molecules, cytokines, growth factors, and proteases have recently been identified as downstream targets of PAR-1 and have been shown to modulate interactions between tumor cells and the microenvironment in the process of melanoma growth and metastasis. Inhibiting such interactions by targeting PAR-1 could potentially be a useful therapeutic modality for melanoma patients. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009534      PMCID: PMC3206157          DOI: 10.1158/0008-5472.CAN-11-1432

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1.

Authors:  Claire J Chalmers; Kathryn Balmanno; Kathryn Hadfield; Rebecca Ley; Simon J Cook
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

2.  Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.

Authors:  Dalila Darmoul; Valérie Gratio; Hélène Devaud; Thérèse Lehy; Marc Laburthe
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines.

Authors:  Christopher H Chay; Carlton R Cooper; James D Gendernalik; Saravana M Dhanasekaran; Arul M Chinnaiyan; Mark A Rubin; Alvin H Schmaier; Kenneth J Pienta
Journal:  Urology       Date:  2002-11       Impact factor: 2.649

4.  Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection.

Authors:  Prosenjit Sen; Ramakrishnan Gopalakrishnan; Hema Kothari; Shiva Keshava; Curtis A Clark; Charles T Esmon; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2011-01-20       Impact factor: 22.113

Review 5.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

Review 6.  Tissue factor, thrombin, and cancer.

Authors:  Frederick R Rickles; Steven Patierno; Patricia M Fernandez
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

7.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

8.  Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion.

Authors:  Michelle A Booden; Lynn B Eckert; Channing J Der; JoAnn Trejo
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

9.  Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective.

Authors:  Tong Cheng; Dong Liu; John H Griffin; José A Fernández; Francis Castellino; Elliot D Rosen; Kenji Fukudome; Berislav V Zlokovic
Journal:  Nat Med       Date:  2003-02-03       Impact factor: 53.440

10.  Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors.

Authors:  Susan R Wilson; Sandra Gallagher; Kate Warpeha; Susan J Hawthorne
Journal:  Prostate       Date:  2004-07-01       Impact factor: 4.104

View more
  34 in total

1.  MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.

Authors:  Peter C Lucas; Linda M McAllister-Lucas; J Randall McAuley; Kelly M Bailey; Prasanna Ekambaram; Linda R Klei; Heejae Kang; Dong Hu; Tanner J Freeman; Vincent J Concel; Nathaniel E Hubel; Jia-Ying Lloyd Lee; Hanna B Klei; Jing Cheng; Preethiya Sekar; Rachel E Bridwell; Lidija Covic
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

2.  Identification of FLOT2 as a novel target for microRNA-34a in melanoma.

Authors:  Rui Liu; Huiqing Xie; Chengqun Luo; Zizi Chen; Xiao Zhou; Kun Xia; Xiang Chen; Ming Zhou; Peiguo Cao; Ke Cao; Jianda Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-18       Impact factor: 4.553

3.  Thrombin drives tumorigenesis in colitis-associated colon cancer.

Authors:  Brian Turpin; Whitney Miller; Leah Rosenfeldt; Keith Kombrinck; Matthew J Flick; Kris A Steinbrecher; Eleana Harmel-Laws; Eric S Mullins; Maureen Shaw; David P Witte; Alexey Revenko; Brett Monia; Joseph S Palumbo
Journal:  Cancer Res       Date:  2014-04-07       Impact factor: 12.701

4.  The Role of Thrombin and Cell Contractility in Regulating Clustering and Collective Migration of Corneal Fibroblasts in Different ECM Environments.

Authors:  Miguel Miron-Mendoza; Eric Graham; Pouriska Kivanany; Jonathan Quiring; W Matthew Petroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-03       Impact factor: 4.799

Review 5.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

6.  G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene.

Authors:  Laura Regué; Fan Mou; Joseph Avruch
Journal:  Bioessays       Date:  2013-03-01       Impact factor: 4.345

7.  PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.

Authors:  R Auvergne; C Wu; A Connell; S Au; A Cornwell; M Osipovitch; A Benraiss; S Dangelmajer; H Guerrero-Cazares; A Quinones-Hinojosa; S A Goldman
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

8.  Lung cancer with gastrointestinal metastasis - review of theories of metastasis with three rare case descriptions.

Authors:  Rohtesh S Mehta; Andrew D Liman; Vida A Passero; Agnes K Liman
Journal:  Cancer Microenviron       Date:  2013-08-21

9.  Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration.

Authors:  Ravisekhar Gadepalli; Sivareddy Kotla; Mark R Heckle; Shailendra K Verma; Nikhlesh K Singh; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2013-09-11       Impact factor: 5.157

Review 10.  MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.

Authors:  Swadesh K Das; Santanu Maji; Stephen L Wechman; Praveen Bhoopathi; Anjan K Pradhan; Sarmistha Talukdar; Devanand Sarkar; Joseph Landry; Chunqing Guo; Xiang-Yang Wang; Webster K Cavenee; Luni Emdad; Paul B Fisher
Journal:  Pharmacol Res       Date:  2020-02-13       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.